{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:47:43Z","timestamp":1768999663399,"version":"3.49.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"TRANSPLANTEX NG","award":["ITI 2021-2028"],"award-info":[{"award-number":["ITI 2021-2028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-025-00739-y","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:13:38Z","timestamp":1753521218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Complete Complement Factor I (CFI) deficiency: a systematic review of forty-nine patients including three novel cases"],"prefix":"10.1186","volume":"26","author":[{"given":"Erta","family":"Rajabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa Choroom","family":"Kheirabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrin Alipour","family":"Olyaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Molitor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohadese Sadat Mousavi","family":"Khorshidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morteza","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parastoo","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohadese","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Carapito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Shahrooei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiamak","family":"Bahram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Parvaneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"739_CR1","doi-asserted-by":"publisher","first-page":"578069","DOI":"10.3389\/fimmu.2020.578069","volume":"11","author":"ECW de Boer","year":"2020","unstructured":"de Boer ECW, van Mourik AG, Jongerius I. Therapeutic lessons to be learned from the role of complement regulators as double-edged sword in health and disease. Front Immunol. 2020;11:578069.","journal-title":"Front Immunol"},{"issue":"3\u20134","key":"739_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2119\/molmed.2010.00149","volume":"17","author":"C Ehrnthaller","year":"2011","unstructured":"Ehrnthaller C, Ignatius A, Gebhard F, Huber-Lang M. New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol Med. 2011;17(3\u20134):317\u201329.","journal-title":"Mol Med"},{"issue":"9","key":"739_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11(9):785\u201397.","journal-title":"Nat Immunol"},{"issue":"1","key":"739_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00441-010-1034-0","volume":"343","author":"JV Sarma","year":"2011","unstructured":"Sarma JV, Ward PA. The complement system. Cell Tissue Res. 2011;343(1):227\u201335.","journal-title":"Cell Tissue Res"},{"issue":"2","key":"739_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1556\/EuJMI.2.2012.2.2","volume":"2","author":"PN Nesargikar","year":"2012","unstructured":"Nesargikar PN, Spiller B, Chavez R. The complement system: history, pathways, cascade and inhibitors. Eur J Microbiol Immunol (Bp). 2012;2(2):103\u201311.","journal-title":"Eur J Microbiol Immunol (Bp)"},{"issue":"6","key":"739_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","volume":"33","author":"M Noris","year":"2013","unstructured":"Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol. 2013;33(6):479\u201392.","journal-title":"Semin Nephrol"},{"issue":"4","key":"739_CR7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.cll.2019.07.006","volume":"39","author":"M Ling","year":"2019","unstructured":"Ling M, Murali M. Analysis of the Complement System in the Clinical Immunology Laboratory. Clin Lab Med. 2019;39(4):579\u201390.","journal-title":"Clin Lab Med"},{"issue":"2\u20134","key":"739_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0161-5890(03)00110-X","volume":"40","author":"D Turnberg","year":"2003","unstructured":"Turnberg D, Botto M. The regulation of the complement system: insights from genetically-engineered mice. Mol Immunol. 2003;40(2\u20134):145\u201353.","journal-title":"Mol Immunol"},{"issue":"1","key":"739_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1006\/geno.1994.1585","volume":"24","author":"TJ Vyse","year":"1994","unstructured":"Vyse TJ, Bates GP, Walport MJ, Morley BJ. The organization of the human complement factor I gene (IF): a member of the serine protease gene family. Genomics. 1994;24(1):90\u20138.","journal-title":"Genomics"},{"issue":"14","key":"739_CR10","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.molimm.2011.04.004","volume":"48","author":"SC Nilsson","year":"2011","unstructured":"Nilsson SC, Sim RB, Lea SM, Fremeaux-Bacchi V, Blom AM. Complement factor I in health and disease. Mol Immunol. 2011;48(14):1611\u201320.","journal-title":"Mol Immunol"},{"issue":"1","key":"739_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molimm.2007.05.004","volume":"45","author":"D Kavanagh","year":"2008","unstructured":"Kavanagh D, Richards A, Noris M, Hauhart R, Liszewski MK, Karpman D, et al. Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome. Mol Immunol. 2008;45(1):95\u2013105.","journal-title":"Mol Immunol"},{"issue":"1","key":"739_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0378-1119(97)00632-X","volume":"208","author":"JO Minta","year":"1998","unstructured":"Minta JO, Fung M, Turner S, Eren R, Zemach L, Rits M, Goldberger G. Cloning and characterization of the promoter for the human complement factor I (C3b\/C4b inactivator) gene. Gene. 1998;208(1):17\u201324.","journal-title":"Gene"},{"issue":"5","key":"739_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0161-5890(94)00151-P","volume":"32","author":"MJ Wong","year":"1995","unstructured":"Wong MJ, Goldberger G, Isenman DE, Minta JO. Processing of human factor I in COS-1 cells co-transfected with factor I and paired basic amino acid cleaving enzyme (PACE) cDNA. Mol Immunol. 1995;32(5):379\u201387.","journal-title":"Mol Immunol"},{"issue":"8","key":"739_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nsmb.3427","volume":"24","author":"X Xue","year":"2017","unstructured":"Xue X, Wu J, Ricklin D, Forneris F, Di Crescenzio P, Schmidt CQ, et al. Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses. Nat Struct Mol Biol. 2017;24(8):643\u201351.","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"739_CR15","doi-asserted-by":"publisher","first-page":"152410","DOI":"10.1016\/j.imbio.2023.152410","volume":"228","author":"TM Hallam","year":"2023","unstructured":"Hallam TM, Sharp SJ, Andreadi A, Kavanagh D. Complement factor I: regulatory nexus, driver of immunopathology, and therapeutic. Immunobiology. 2023;228(5):152410.","journal-title":"Immunobiology"},{"issue":"4","key":"739_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.imbio.2019.05.003","volume":"224","author":"PJ Lachmann","year":"2019","unstructured":"Lachmann PJ. The story of complement factor I. Immunobiology. 2019;224(4):511\u20137.","journal-title":"Immunobiology"},{"issue":"14","key":"739_CR17","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.molimm.2011.05.001","volume":"48","author":"L Skattum","year":"2011","unstructured":"Skattum L, van Deuren M, van der Poll T, Truedsson L. Complement deficiency states and associated infections. Mol Immunol. 2011;48(14):1643\u201355.","journal-title":"Mol Immunol"},{"key":"739_CR18","doi-asserted-by":"publisher","first-page":"929483","DOI":"10.3389\/fcimb.2022.929483","volume":"12","author":"E Gil","year":"2022","unstructured":"Gil E, Noursadeghi M, Brown JS. Streptococcus pneumoniae interactions with the complement system. Front Cell Infect Microbiol. 2022;12:929483.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"739_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1055\/s-2006-939771","volume":"32","author":"D Kavanagh","year":"2006","unstructured":"Kavanagh D, Goodship TH. Membrane cofactor protein and factor I: mutations and transplantation. Semin Thromb Hemost. 2006;32(2):155\u20139.","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"739_CR20","doi-asserted-by":"publisher","first-page":"100265","DOI":"10.1016\/j.xops.2022.100265","volume":"3","author":"JM Seddon","year":"2023","unstructured":"Seddon JM, Rosner B, De D, Huan T, Java A, Atkinson J. Rare dysfunctional complement factor i genetic variants and progression to advanced age-related macular degeneration. Ophthalmol Sci. 2023;3(2):100265.","journal-title":"Ophthalmol Sci"},{"issue":"55","key":"739_CR21","first-page":"1","volume":"7","author":"ACL Macedo","year":"2016","unstructured":"Macedo ACL, Isaac L. Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway. Front Immunol. 2016;7(55):1\u20137.","journal-title":"Front Immunol."},{"key":"739_CR22","doi-asserted-by":"publisher","first-page":"866330","DOI":"10.3389\/fimmu.2022.866330","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Goodfellow RX, Ghiringhelli Borsa N, Dunlop HC, Presti SA, Meyer NC, et al. Complement Factor I variants in complement-mediated renal diseases. Front Immunol. 2022;13:866330.","journal-title":"Front Immunol"},{"issue":"7","key":"739_CR23","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1681\/ASN.2005010103","volume":"16","author":"D Kavanagh","year":"2005","unstructured":"Kavanagh D, Kemp EJ, Mayland E, Winney RJ, Duffield JS, Warwick G, et al. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16(7):2150\u20135.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"739_CR24","doi-asserted-by":"publisher","first-page":"e220","DOI":"10.1212\/WNL.0000000000207079","volume":"101","author":"E Levit","year":"2023","unstructured":"Levit E, Leon J, Lincoln MR. Pearls & Oy-sters: Homozygous Complement Factor I deficiency presenting as fulminant relapsing complement-Mediated CNS Vasculitis. Neurology. 2023;101(2):e220\u20133.","journal-title":"Neurology"},{"issue":"1","key":"739_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89.","journal-title":"Syst Rev"},{"issue":"7","key":"739_CR26","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1007\/s10875-022-01352-z","volume":"42","author":"A Bousfiha","year":"2022","unstructured":"Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity. J Clin Immunol. 2022;42(7):1508\u201320.","journal-title":"J Clin Immunol"},{"issue":"8","key":"739_CR27","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s10875-023-01562-z","volume":"43","author":"MS Mousavi Khorshidi","year":"2023","unstructured":"Mousavi Khorshidi MS, Seeleuthner Y, Chavoshzadeh Z, Behfar M, Hamidieh AA, Alimadadi H, et al. Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population. J Clin Immunol. 2023;43(8):1941\u201352.","journal-title":"J Clin Immunol."},{"key":"739_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1172-7-42","volume":"7","author":"M Alba-Dom\u00ednguez","year":"2012","unstructured":"Alba-Dom\u00ednguez M, L\u00f3pez-Lera A, Garrido S, Nozal P, Gonz\u00e1lez-Granado I, Melero J, et al. Complement factor I deficiency: a not so rare immune defect: characterization of new mutations and the first large gene deletion. Orphanet J Rare Dis. 2012;7:42.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"739_CR29","doi-asserted-by":"publisher","first-page":"e689","DOI":"10.1212\/NXI.0000000000000689","volume":"7","author":"T Altmann","year":"2020","unstructured":"Altmann T, Torvell M, Owens S, Mitra D, Sheerin NS, Morgan BP, et al. Complement factor I deficiency: a potentially treatable cause of fulminant cerebral inflammation. Neurol Neuroimmunol Neuroinflamm. 2020;7(3):e689.","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"2","key":"739_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1046\/j.1365-2249.2003.02077.x","volume":"131","author":"GV Baracho","year":"2003","unstructured":"Baracho GV, Nudelman V, Isaac L. Molecular characterization of homozygous hereditary factor I deficiency. Clin Exp Immunol. 2003;131(2):280\u20136.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"739_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.clim.2015.05.004","volume":"160","author":"JT Bay","year":"2015","unstructured":"Bay JT, Katzenstein TL, Kofoed K, Patel D, Skjoedt MO, Garred P, Schejbel L. Novel CFI mutation in a patient with leukocytoclastic vasculitis may redefine the clinical spectrum of Complement Factor I deficiency. Clin Immunol. 2015;160(2):315\u20138.","journal-title":"Clin Immunol"},{"issue":"4","key":"739_CR32","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ki.2009.472","volume":"77","author":"F Bienaime","year":"2010","unstructured":"Bienaime F, Dragon-Durey MA, Regnier CH, Nilsson SC, Kwan WH, Blouin J, et al. Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome. Kidney Int. 2010;77(4):339\u201349.","journal-title":"Kidney Int"},{"issue":"9","key":"739_CR33","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.ekir.2019.05.1156","volume":"4","author":"I Boudhabhay","year":"2019","unstructured":"Boudhabhay I, Fr\u00e9meaux-Bacchi V, Roumenina LT, Moktefi A, Goujon JM, Matignon M, et al. Glomerulonephritis With Isolated C3 deposits as a manifestation of subtotal factor I Deficiency. Kidney Int Rep. 2019;4(9):1354\u20138.","journal-title":"Kidney Int Rep"},{"key":"739_CR34","doi-asserted-by":"crossref","unstructured":"Bouzroud W, Tazzite A, yousra I, Gazzaz B, Dehbi H. Complement Factor I deficiency: A novel homozygous CFI gene mutation. SAGE Open Medical Case Reports. 2022;10:2050313X221105992.","DOI":"10.1177\/2050313X221105992"},{"issue":"1","key":"739_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s10875-012-9767-z","volume":"33","author":"L Broderick","year":"2013","unstructured":"Broderick L, Gandhi C, Mueller JL, Putnam CD, Shayan K, Giclas PC, et al. Mutations of complement factor I and potential mechanisms of neuroinflammation in acute hemorrhagic leukoencephalitis. J Clin Immunol. 2013;33(1):162\u201371.","journal-title":"J Clin Immunol"},{"key":"739_CR36","doi-asserted-by":"crossref","unstructured":"Franco-Jarava C, \u00c1lvarez de la Campa E, Solanich X, Morandeira-Rego F, Mas-Bosch V, Garc\u00eda-Prat M, et al. Early Versus Late Diagnosis of Complement Factor I deficiency: clinical consequences illustrated in two families with novel homozygous CFI Mutations. J Clin Immunol. 2017;37(8):781\u20139.","DOI":"10.1007\/s10875-017-0447-x"},{"key":"739_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.imlet.2016.04.011","volume":"174","author":"C Franco-Jarava","year":"2016","unstructured":"Franco-Jarava C, Colobran R, Mestre-Torres J, Vargas V, Pujol-Borrell R, Hern\u00e1ndez-Gonz\u00e1lez M. Clinical laboratory standard capillary protein electrophoresis alerted of a low C3 state and lead to the identification of a Factor I deficiency due to a novel homozygous mutation. Immunol Lett. 2016;174:19\u201322.","journal-title":"Immunol Lett"},{"issue":"8","key":"739_CR38","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s10875-013-9944-8","volume":"33","author":"F Haerynck","year":"2013","unstructured":"Haerynck F, Stordeur P, Vandewalle J, Van Coster R, Bordon V, De Baets F, et al. Complete factor I deficiency due to dysfunctional factor I with recurrent aseptic meningo-encephalitis. J Clin Immunol. 2013;33(8):1293\u2013301.","journal-title":"J Clin Immunol"},{"issue":"2","key":"739_CR39","doi-asserted-by":"publisher","first-page":"e200191","DOI":"10.1212\/NXI.0000000000200191","volume":"11","author":"V Massey","year":"2024","unstructured":"Massey V, Nguyen CTE, Fran\u00e7ois T, De Bruycker JJ, Bonnefoy A, Lapeyraque AL, Decaluwe H. CNS inflammation as the first sign of complement factor I deficiency. Neurol Neuroimmunol Neuroinflamm. 2024;11(2):e200191.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"739_CR40","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3389\/fimmu.2018.00735","volume":"9","author":"S Nanthapisal","year":"2018","unstructured":"Nanthapisal S, Eleftheriou D, Gilmour K, Leone V, Ramnath R, Omoyinmi E, et al. Cutaneous vasculitis and recurrent infection caused by deficiency in complement factor I. Front Immunol. 2018;9:735.","journal-title":"Front Immunol"},{"issue":"1","key":"739_CR41","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/eji.200838702","volume":"39","author":"SC Nilsson","year":"2009","unstructured":"Nilsson SC, Trouw LA, Renault N, Miteva MA, Genel F, Zelazko M, et al. Genetic, molecular and functional analyses of complement factor I deficiency. Eur J Immunol. 2009;39(1):310\u201323.","journal-title":"Eur J Immunol"},{"issue":"8","key":"739_CR42","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.molimm.2011.01.012","volume":"48","author":"IM Nita","year":"2011","unstructured":"Nita IM, Genel F, Nilsson SC, Smart J, Truedsson L, Choo S, Blom AM. Molecular characterization of two novel cases of complete complement inhibitor Factor I deficiency. Mol Immunol. 2011;48(8):1068\u201372.","journal-title":"Mol Immunol"},{"issue":"10","key":"739_CR43","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1016\/j.molimm.2008.02.008","volume":"45","author":"IM Ponce-Castro","year":"2008","unstructured":"Ponce-Castro IM, Gonz\u00e1lez-Rubio C, Delgado-Cervi\u00f1o EM, Abarrategui-Garrido C, Font\u00e1n G, S\u00e1nchez-Corral P, L\u00f3pez-Trascasa M. Molecular characterization of Complement Factor I deficiency in two Spanish families. Mol Immunol. 2008;45(10):2764\u201371.","journal-title":"Mol Immunol"},{"key":"739_CR44","doi-asserted-by":"crossref","unstructured":"Rodriguez KM, Vaught J, Dilley M, Ellsworth K, Heinen A, Abud EM, et al. Rapid genome sequencing identifies novel variants in complement factor I. Cold Spring Harb Mol Case Stud. 2022;8(7): a006239.","DOI":"10.1101\/mcs.a006239"},{"key":"739_CR45","doi-asserted-by":"crossref","unstructured":"Shields AM, Pagnamenta AT, Pollard AJ, O, Taylor JC, Allroggen H, et al. Classical and Non-classical Presentations of Complement Factor I Deficiency: Two Contrasting Cases Diagnosed via Genetic and Genomic Methods. Frontiers in Immunology. 2019;7(10):1150.","DOI":"10.3389\/fimmu.2019.01150"},{"issue":"1","key":"739_CR46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/ki.2011.291","volume":"81","author":"A Tortajada","year":"2012","unstructured":"Tortajada A, Pinto S, Mart\u00ednez-Ara J, L\u00f3pez-Trascasa M, S\u00e1nchez-Corral P, de C\u00f3rdoba SR. Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance. Kidney Int. 2012;81(1):56\u201363.","journal-title":"Kidney Int"},{"issue":"3","key":"739_CR47","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/cei.13490","volume":"202","author":"S Ugrinovic","year":"2020","unstructured":"Ugrinovic S, Firth H, Kavanagh D, Gouliouris T, Gurugama P, Baxendale H, et al. Primary pneumococcal peritonitis can be the first presentation of a familial complement factor I deficiency(1). Clin Exp Immunol. 2020;202(3):379\u201383.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"739_CR48","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1172\/JCI118515","volume":"97","author":"TJ Vyse","year":"1996","unstructured":"Vyse TJ, Morley BJ, Bartok I, Theodoridis EL, Davies KA, Webster AD, Walport MJ. The molecular basis of hereditary complement factor I deficiency. J Clin Invest. 1996;97(4):925\u201333.","journal-title":"J Clin Invest"},{"issue":"1","key":"739_CR49","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12882-018-0952-z","volume":"19","author":"J Wen","year":"2018","unstructured":"Wen J, Wang W, Xu F, Sun J, Chen J, Ni X. C3 glomerulonephritis and thrombotic microangiopathy of renal allograft after pulmonary infection in a male with concomitant two complement factor I gene variations: a case report. BMC Nephrol. 2018;19(1):148.","journal-title":"BMC Nephrol"},{"issue":"2","key":"739_CR50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nmeth.3739","volume":"13","author":"Y Itan","year":"2016","unstructured":"Itan Y, Shang L, Boisson B, Ciancanelli MJ, Markle JG, Martinez-Barricarte R, et al. The mutation significance cutoff: gene-level thresholds for variant predictions. Nat Methods. 2016;13(2):109\u201310.","journal-title":"Nat Methods"},{"issue":"14","key":"739_CR51","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/hmg\/ddaa114","volume":"29","author":"S de Jong","year":"2020","unstructured":"de Jong S, Volokhina EB, de Breuk A, Nilsson SC, de Jong EK, van der Kar N, et al. Effect of rare coding variants in the CFI gene on Factor I expression levels. Hum Mol Genet. 2020;29(14):2313\u201324.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"739_CR52","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ng.2741","volume":"45","author":"JM Seddon","year":"2013","unstructured":"Seddon JM, Yu Y, Miller EC, Reynolds R, Tan PL, Gowrisankar S, et al. Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet. 2013;45(11):1366\u201370.","journal-title":"Nat Genet"},{"issue":"2","key":"739_CR53","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jaci.2020.08.014","volume":"147","author":"L Naesens","year":"2021","unstructured":"Naesens L, Smet J, Tavernier SJ, Schelstraete P, Hoste L, Lambrecht S, et al. Plasma C3d levels as a diagnostic marker for complete complement factor I deficiency. J Allergy Clin Immunol. 2021;147(2):749-53.e2.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"739_CR54","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1056\/NEJM197002122820701","volume":"282","author":"CA Alper","year":"1970","unstructured":"Alper CA, Abramson N, Johnston RB Jr, Jandl JH, Rosen FS. Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). N Engl J Med. 1970;282(7):349\u201354.","journal-title":"N Engl J Med"},{"issue":"1","key":"739_CR55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molimm.2010.08.016","volume":"48","author":"LA Fraczek","year":"2010","unstructured":"Fraczek LA, Martin BK. Transcriptional control of genes for soluble complement cascade regulatory proteins. Mol Immunol. 2010;48(1):9\u201313.","journal-title":"Mol Immunol"},{"issue":"1","key":"739_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4049\/jimmunol.107.1.19","volume":"107","author":"N Abramson","year":"1971","unstructured":"Abramson N, Alper CA, Lachmann PJ, Rosen FS, Jandl JH. Deficiency of C3 inactivator in man. J Immunol. 1971;107(1):19\u201327.","journal-title":"J Immunol"},{"issue":"8","key":"739_CR57","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/00365540510034536","volume":"37","author":"F Genel","year":"2005","unstructured":"Genel F, Sj\u00f6holm AG, Skattum L, Truedsson L. Complement factor I deficiency associated with recurrent infections, vasculitis and immune complex glomerulonephritis. Scand J Infect Dis. 2005;37(8):615\u20138.","journal-title":"Scand J Infect Dis"},{"key":"739_CR58","doi-asserted-by":"crossref","unstructured":"Panelius J, Meri S. Complement System in Dermatological Diseases\u2013 Fire Under the Skin. Frontiers in Medicine. 2015;2.","DOI":"10.3389\/fmed.2015.00003"},{"key":"739_CR59","doi-asserted-by":"crossref","unstructured":"Stevens NE, Cowin AJ, Kopecki Z. Skin Barrier and Autoimmunity\u2014Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin. Frontiers in Immunology. 2019;10.","DOI":"10.3389\/fimmu.2019.01089"},{"issue":"1","key":"739_CR60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","volume":"67","author":"CM Nester","year":"2015","unstructured":"Nester CM, Barbour T, de Cordoba SR, Dragon-Durey MA, Fremeaux-Bacchi V, Goodship TH, et al. Atypical aHUS: State of the art. Mol Immunol. 2015;67(1):31\u201342.","journal-title":"Mol Immunol"},{"issue":"9","key":"739_CR61","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1084\/jem.185.9.1619","volume":"185","author":"F Tedesco","year":"1997","unstructured":"Tedesco F, Pausa M, Nardon E, Introna M, Mantovani A, Dobrina A. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J Exp Med. 1997;185(9):1619\u201327.","journal-title":"J Exp Med"},{"key":"739_CR62","doi-asserted-by":"publisher","first-page":"827815","DOI":"10.3389\/fimmu.2021.827815","volume":"12","author":"H Lindahl","year":"2021","unstructured":"Lindahl H, Bryceson YT. Neuroinflammation associated with inborn errors of immunity. Front Immunol. 2021;12:827815.","journal-title":"Front Immunol"},{"issue":"1","key":"739_CR63","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1385\/IR:36:1:197","volume":"36","author":"FR Toapanta","year":"2006","unstructured":"Toapanta FR, Ross TM. Complement-mediated activation of the adaptive immune responses. Immunol Res. 2006;36(1):197\u2013210.","journal-title":"Immunol Res"},{"issue":"4","key":"739_CR64","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s10875-020-00754-1","volume":"40","author":"N Brodszki","year":"2020","unstructured":"Brodszki N, Frazer-Abel A, Grumach AS, Kirschfink M, Litzman J, Perez E, et al. European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management. J Clin Immunol. 2020;40(4):576\u201391.","journal-title":"J Clin Immunol"},{"issue":"6","key":"739_CR65","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1046\/j.1365-3083.2001.00931.x","volume":"53","author":"N Amadei","year":"2001","unstructured":"Amadei N, Baracho GV, Nudelman V, Bastos W, Florido MP, Isaac L. Inherited complete factor I deficiency associated with systemic lupus erythematosus, higher susceptibility to infection and low levels of factor H. Scand J Immunol. 2001;53(6):615\u201321.","journal-title":"Scand J Immunol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00739-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-025-00739-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00739-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:56:36Z","timestamp":1757307396000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-025-00739-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["739"],"URL":"https:\/\/doi.org\/10.1186\/s12865-025-00739-y","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Children's Medical Center Institutional Ethics Committee, affiliated with the Tehran University of Medical Sciences, approved the study. Informed consent for participating in the study was obtained from the patients or their parents. Our study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for publication of data was obtained from the patients or their parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}